Letters
Open Access
Response to: “Consistent terminology for medication-related problems in pharmacogenomic cases”
Theo Korchia, Ridha Joober, Raphaelle Richieri, Priyadharshini Sabesan and Lena Palaniyappan
J Psychiatry Neurosci May 12, 2023 48 (3) E153; DOI: https://doi.org/10.1503/jpn.230048-l
Theo Korchia
From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Joober, Sabesan, Palaniyappan); the Lakeshore Hospital, Department of Psychiatry, McGill University, Montréal, Que. (Sabesan, Palaniyappan); the Robarts Research Institute, Western University, London, Ont. (Sabesan, Palaniyappan); the Department of Psychiatry, La Conception University Hospital, Marseille, France (Korchia, Richieri); and CNRS, Centrale Marseille, Institut Fresnel, Aix Marseille University, Marseille, France (Korchia, Richieri)
MDRidha Joober
From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Joober, Sabesan, Palaniyappan); the Lakeshore Hospital, Department of Psychiatry, McGill University, Montréal, Que. (Sabesan, Palaniyappan); the Robarts Research Institute, Western University, London, Ont. (Sabesan, Palaniyappan); the Department of Psychiatry, La Conception University Hospital, Marseille, France (Korchia, Richieri); and CNRS, Centrale Marseille, Institut Fresnel, Aix Marseille University, Marseille, France (Korchia, Richieri)
MD, PhDRaphaelle Richieri
From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Joober, Sabesan, Palaniyappan); the Lakeshore Hospital, Department of Psychiatry, McGill University, Montréal, Que. (Sabesan, Palaniyappan); the Robarts Research Institute, Western University, London, Ont. (Sabesan, Palaniyappan); the Department of Psychiatry, La Conception University Hospital, Marseille, France (Korchia, Richieri); and CNRS, Centrale Marseille, Institut Fresnel, Aix Marseille University, Marseille, France (Korchia, Richieri)
MD, PhDPriyadharshini Sabesan
From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Joober, Sabesan, Palaniyappan); the Lakeshore Hospital, Department of Psychiatry, McGill University, Montréal, Que. (Sabesan, Palaniyappan); the Robarts Research Institute, Western University, London, Ont. (Sabesan, Palaniyappan); the Department of Psychiatry, La Conception University Hospital, Marseille, France (Korchia, Richieri); and CNRS, Centrale Marseille, Institut Fresnel, Aix Marseille University, Marseille, France (Korchia, Richieri)
MDLena Palaniyappan
From the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montréal, Que. (Korchia, Joober, Sabesan, Palaniyappan); the Lakeshore Hospital, Department of Psychiatry, McGill University, Montréal, Que. (Sabesan, Palaniyappan); the Robarts Research Institute, Western University, London, Ont. (Sabesan, Palaniyappan); the Department of Psychiatry, La Conception University Hospital, Marseille, France (Korchia, Richieri); and CNRS, Centrale Marseille, Institut Fresnel, Aix Marseille University, Marseille, France (Korchia, Richieri)
MD, PhDIn this issue
Article tools
Response to: “Consistent terminology for medication-related problems in pharmacogenomic cases”
Theo Korchia, Ridha Joober, Raphaelle Richieri, Priyadharshini Sabesan, Lena Palaniyappan
J Psychiatry Neurosci May 2023, 48 (3) E153; DOI: 10.1503/jpn.230048-l
Related Articles
Cited By...
- No citing articles found.